{
  "ticker": "REGN",
  "year": 2025,
  "quarter": 4,
  "last_updated": "2025-12-16T08:38:11.644723",
  "count": 11,
  "transactions": [
    {
      "id": 60,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2025-12-09",
      "transaction_shares": "2552",
      "transaction_price": "701.51",
      "transaction_type": "F",
      "shares_after_transaction": "21673"
    },
    {
      "id": 62,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2025-12-09",
      "transaction_shares": "1021",
      "transaction_price": "701.51",
      "transaction_type": "F",
      "shares_after_transaction": "14349"
    },
    {
      "id": 67,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2025-12-09",
      "transaction_shares": "4229",
      "transaction_price": "701.51",
      "transaction_type": "F",
      "shares_after_transaction": "47833"
    },
    {
      "id": 69,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2025-12-09",
      "transaction_shares": "172723",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "369668"
    },
    {
      "id": 70,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2025-12-09",
      "transaction_shares": "146815",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "442334"
    },
    {
      "id": 61,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2025-12-05",
      "transaction_shares": "3715",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "26131"
    },
    {
      "id": 63,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2025-12-05",
      "transaction_shares": "2476",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "30913"
    },
    {
      "id": 64,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2025-12-05",
      "transaction_shares": "2476",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "16706"
    },
    {
      "id": 65,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Pitofsky Jason",
      "reporting_owner_cik": "0002009236",
      "reporting_owner_position": "VP Controller",
      "transaction_date": "2025-12-05",
      "transaction_shares": "2064",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6297"
    },
    {
      "id": 66,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2025-12-05",
      "transaction_shares": "3027",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "19292"
    },
    {
      "id": 68,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2025-12-05",
      "transaction_shares": "3715",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "53761"
    }
  ]
}